Reduced adenosine A 2a receptor-mediated efferent arteriolar vasodilation contributes to diabetes-induced glomerular hyperfiltration

Kidney International

Volumn 87, Issue 1, 2015, Pages 109-115

  Persson, Patrik ^a   Hansell, Peter ^a   Palm, Fredrik ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Diabetes mellitus; Glomerular filtration rate; Glomerular hyperfiltration; Renal hemodynamics

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; FLOW RATE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VASODILATATION; ANIMAL; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GLOMERULUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ARTERIOLES; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; VASODILATION;

EID: 84920262044     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.219     Document Type: Article

References (47)

1. Moriya T, Tsuchiya A, Okizaki S et al. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo-and microalbuminuric type 2 diabetes. Kidney Int 2012; 81: 486-493.
2. Thomas MC, Moran JL, Harjutsalo V et al. Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? Diabetologia 2012; 55: 1505-1513.
3. Ito A, Uriu K, Inada Y et al. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat. J Lab Clin Med 2001; 138: 177-185.
4. Vallon V, Richter K, Blantz RC et al. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999; 10: 2569-2576.
5. Ditzel J, Junker K. Abnormal glomerular filtration rate, renal plasma flow, and renal protein excretion in recent and short-term diabetics. Br Med J 1972; 2: 13-19.
6. Nordquist L, Brown R, Fasching A et al. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol Renal Physiol 2009; 297: F1265-F1272.
7. Persson P, Hansell P, Palm F. NADPH oxidase inhibition reduces tubular sodium transport and improves kidney oxygenation in diabetes. Am J Physiol Regul Integr Comp Physiol 2012; 302: R1443-R1449.
8. Berg UB, Torbjornsdotter TB, Jaremko G et al. Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 1998; 41: 1047-1056.
9. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971; 28: 91-100.
10. Persson P, Hansell P, Palm F. Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol (Oxf) 2010; 200: 3-10.
11. Jensen PK, Christiansen JS, Steven K et al. Renal function in streptozotocin-diabetic rats. Diabetologia 1981; 21: 409-414.
12. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410-415.
13. Sallstrom J, Eriksson T, Fredholm BB et al. Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A-receptor deficient mice. Acta Physiol (Oxf) 2014; 210: 440-445.
14. Seyer-Hansen K, Hansen J, Gundersen HJ. Renal hypertrophy in experimental diabetes. A morphometric study. Diabetologia 1980; 18: 501-505.
15. Singh R, Singh AK, Leehey DJ. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 2005; 288: F1183-F1190.
16. Sochett EB, Cherney DZ, Curtis JR et al. Impact of renin angiotensin system modulation on The hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006; 17: 1703-1709.
17. Sallstrom J, Carlsson PO, Fredholm BB et al. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking The tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 2007; 190: 253-259.
18. Faulhaber-Walter R, Chen L, Oppermann M et al. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol 2008; 19: 722-730.
19. Vallon V, Schroth J, Satriano J et al. Adenosine A(1) receptors determine glomerular hyperfiltration and The salt paradox in early streptozotocin diabetes mellitus. Nephron Physiol 2009; 111: p30-p38.
20. Vitzthum H, Weiss B, Bachleitner W et al. Gene expression of adenosine receptors along The nephron. Kidney Int 2004; 65: 1180-1190.
21. Fredholm BB, Irenius E, Kull B et al. Comparison of The potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 2001; 61: 443-448.
22. Nakamoto H, Ogasawara Y, Kajiya F. Visualisation of The effects of dilazep on rat afferent and efferent arterioles in vivo. Hypertens Res 2008; 31: 315-324.
23. Freissmuth M, Nanoff C, Tuisl E et al. Stimulation of adenylate cyclase activity via A2-adenosine receptors in isolated tubules of The rabbit renal cortex. Eur J Pharmacol 1987; 138: 137-140.
24. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in The preglomerular microcirculation. Am J Physiol Renal Physiol 2002; 283: F41-F51.
25. Feng MG, Navar LG. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation. Am J Physiol Renal Physiol 2010; 299: F310-F315.
26. Al-Mashhadi RH, Skott O, Vanhoutte PM et al. Activation of A(2) adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int 2009; 75: 793-799.
27. Persson P, Hansell P, Palm F. Adenosine A2 receptor-mediated regulation of renal hemodynamics and glomerular filtration rate is abolished in diabetes. Adv Exp Med Biol 2013; 765: 225-230.
28. Pawelczyk T, Grden M, Rzepko R et al. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am J Pathol 2005; 167: 315-325.
29. Tagawa H, Vander AJ. Effects of adenosine compounds on renal function and renin secretion in dogs. Circ Res 1970; 26: 327-338.
30. Osswald H, Spielman WS, Knox FG. Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 1978; 43: 465-469.
31. Agmon Y, Dinour D, Brezis M. Disparate effects of adenosine A1-and A2-receptor agonists on intrarenal blood flow. Am J Physiol 1993; 265: F802-F806.
32. Zou AP, Nithipatikom K, Li PL et al. Role of renal medullary adenosine in The control of blood flow and sodium excretion. Am J Physiol 1999; 276: R790-R798.
33. Klotz KN. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 382-391.
34. Pflueger AC, Schenk F, Osswald H. Increased sensitivity of The renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. Am J Physiol 1995; 269: F529-F535.
35. Siragy HM, Linden J. Sodium intake markedly alters renal interstitial fluid adenosine. Hypertension 1996; 27: 404-407.
36. Grenz A, Zhang H, Hermes M et al. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 2007; 21: 2863-2873.
37. Grenz A, Bauerle JD, Dalton JH et al. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012; 122: 693-710.
38. Kocic G, Djordjevic V, Vlahovic P et al. Antioxidants modulate adenosine metabolism in rat mesangial cells cultured under high glucose conditions. Ren Fail 2002; 24: 691-701.
39. Lee JG, Kang DG, Yu JR et al. Changes in adenosine deaminase activity in patients with type 2 diabetes mellitus and effect of DPP-4 inhibitor treatment on ADA activity. Diabetes Metab J 2011; 35: 149-158.
40. Pollock CA, Lawrence JR, Field MJ. Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus. Am J Physiol 1991; 260: F946-F952.
41. Ren Y, Garvin JL, Carretero OA. Efferent arteriole tubuloglomerular feedback in The renal nephron. Kidney Int 2001; 59: 222-229.
42. Vallon V, Osswald H. Dipyridamole prevents diabetes-induced alterations of kidney function in rats. Naunyn Schmiedebergs Arch Pharmacol 1994; 349: 217-222.
43. Hiragushi K, Sugimoto H, Shikata K et al. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo-and micro-albuminuric patients with type 2 diabetes. Diabetes Res Clin Pract 2001; 53: 149-159.
44. Palm F, Friederich M, Carlsson PO et al. Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability. Am J Physiol Renal Physiol 2008; 294: F30-F37.
45. Wang CH, Li F, Hiller S et al. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci USA 2011; 108: 2070-2075.
46. Persson MF, Franzen S, Catrina SB et al. Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 2012; 55: 1535-1543.
47. Oken DE, Wolfert AI, Laveri LA et al. Effects of intra-animal nephron heterogeneity on studies of glomerular dynamics. Kidney Int 1985; 27: 871-878.